Chemours (CC) Stock Price

Chemours Price

NYSE·CLOSED
17.92USD+0.74 (+4.22 %)
Market closed

Revenue at Chemours has contracted by 2.2% per year over the past 14 years to 5.81 B USD. Earnings per share have declined at 12.0% per year over the last 11 years. Chemours's net margin stands at -6.6%, down from 9.6% several years earlier. Chemours currently offers a dividend yield of about 2.86%. Analysts set a median price target of 18.36 USD, implying 2.5% above the current price. Of 18 analysts, 12 rate the stock a buy — an overall Buy consensus. Over the past year Chemours shares have gained 28.0%. The stock trades about 71% above its 52-week low.

Chemours stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Chemours over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Chemours stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Chemours's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Chemours Stock Price History
DateChemours Price
7/21/202617.92 USD
7/20/202617.18 USD
7/17/202617.52 USD
7/16/202617.33 USD
7/15/202618.51 USD
7/14/202618.63 USD
7/13/202617.85 USD
7/10/202617.81 USD
7/9/202617.39 USD
7/8/202618.95 USD
7/7/202618.85 USD
7/6/202618.35 USD
7/2/202619.01 USD
7/1/202620.14 USD
6/30/202620.52 USD
6/29/202619.60 USD
6/26/202620.74 USD
6/25/202621.36 USD
6/24/202621.17 USD
6/23/202619.96 USD
6/22/202621.28 USD
6/18/202621.77 USD
6/17/202622.84 USD
6/16/202621.82 USD
6/15/202622.54 USD
6/12/202622.24 USD
6/11/202621.01 USD
6/10/202620.13 USD
6/9/202620.22 USD
6/8/202620.86 USD
6/5/202621.06 USD
6/4/202621.44 USD
6/3/202623.13 USD
6/2/202623.93 USD
6/1/202621.66 USD
5/29/202622.38 USD
5/28/202622.80 USD
5/27/202622.13 USD
5/26/202621.76 USD
5/22/202621.27 USD
5/21/202621.07 USD
5/20/202622.27 USD
5/19/202621.75 USD
5/18/202622.94 USD
5/15/202623.13 USD
5/14/202624.86 USD
5/13/202625.18 USD
5/12/202624.67 USD
5/11/202625.26 USD
5/8/202623.04 USD
5/7/202622.41 USD
5/6/202623.67 USD
5/5/202627.94 USD
5/4/202627.22 USD
5/1/202627.73 USD
4/30/202626.95 USD
4/29/202626.34 USD
4/28/202625.70 USD
4/27/202626.48 USD
4/24/202626.61 USD
4/23/202624.19 USD
4/22/202624.04 USD
4/21/202623.72 USD
4/20/202623.32 USD
4/17/202623.18 USD
4/16/202623.87 USD
4/15/202623.03 USD
4/14/202622.89 USD
4/13/202623.05 USD
4/10/202622.71 USD
4/9/202621.84 USD
4/8/202621.43 USD
4/7/202622.34 USD
4/6/202621.70 USD
4/2/202621.55 USD
4/1/202621.52 USD
3/31/202622.03 USD
3/30/202621.20 USD
3/27/202621.60 USD
3/26/202621.58 USD
3/25/202620.77 USD
3/24/202620.37 USD
3/23/202618.50 USD
3/20/202617.70 USD
3/19/202618.94 USD
3/18/202619.02 USD
3/17/202618.99 USD
3/16/202617.64 USD
3/13/202617.57 USD
3/12/202617.70 USD
3/11/202617.89 USD
3/10/202617.80 USD
3/9/202617.42 USD
3/6/202616.41 USD
3/5/202616.75 USD
3/4/202617.53 USD
3/3/202616.77 USD
3/2/202617.99 USD
2/27/202618.24 USD
2/26/202617.32 USD
2/25/202618.02 USD
2/24/202618.41 USD
2/23/202618.03 USD
2/20/202617.04 USD
2/19/202620.41 USD
2/18/202621.15 USD
2/17/202620.68 USD
2/13/202620.52 USD
2/12/202620.42 USD
2/11/202621.02 USD
2/10/202619.25 USD
2/9/202618.93 USD
2/6/202618.32 USD
2/5/202616.89 USD
2/4/202617.94 USD
2/3/202616.52 USD
2/2/202615.58 USD
1/30/202614.99 USD
1/29/202615.24 USD
1/28/202615.11 USD
1/27/202615.63 USD
1/26/202615.80 USD
1/23/202615.75 USD
1/22/202616.04 USD
1/21/202616.19 USD
1/20/202615.26 USD
1/16/202615.61 USD
1/15/202615.56 USD
1/14/202614.96 USD
1/13/202614.69 USD
1/12/202614.72 USD
1/9/202614.30 USD
1/8/202613.85 USD
1/7/202613.07 USD
1/6/202613.28 USD
1/5/202612.74 USD
1/2/202612.25 USD
12/31/202511.79 USD
12/30/202511.82 USD
12/29/202511.96 USD
12/26/202512.09 USD
12/24/202512.00 USD
12/23/202511.74 USD
12/22/202512.00 USD
12/19/202511.82 USD
12/18/202511.87 USD
12/17/202511.61 USD
12/16/202511.69 USD
12/15/202511.78 USD
12/12/202512.95 USD
12/11/202513.15 USD
12/10/202513.06 USD
12/9/202512.40 USD
12/8/202512.20 USD
12/5/202512.70 USD
12/4/202512.54 USD
12/3/202512.96 USD
12/2/202512.77 USD
12/1/202512.84 USD
11/28/202512.79 USD
11/26/202512.47 USD
11/25/202512.32 USD
11/24/202511.50 USD
11/21/202511.05 USD
11/20/202510.48 USD
11/19/202510.70 USD
11/18/202510.93 USD
11/17/202511.25 USD
11/14/202511.89 USD
11/13/202512.27 USD
11/12/202512.61 USD
11/11/202512.65 USD
11/10/202512.75 USD
11/7/202512.51 USD
11/6/202511.74 USD
11/5/202512.05 USD
11/4/202512.21 USD
11/3/202512.68 USD
10/31/202513.39 USD
10/30/202513.12 USD
10/29/202513.76 USD
10/28/202513.85 USD
10/27/202514.00 USD
10/24/202514.05 USD
10/23/202513.88 USD
10/22/202513.52 USD
10/21/202513.36 USD
10/20/202513.31 USD
10/17/202512.90 USD
10/16/202513.76 USD
10/15/202514.42 USD
10/14/202513.76 USD
10/13/202513.44 USD
10/10/202512.55 USD
10/9/202513.74 USD
10/8/202515.04 USD
10/7/202515.09 USD
10/6/202515.80 USD
10/3/202516.13 USD
10/2/202516.34 USD
10/1/202515.91 USD
9/30/202515.84 USD
9/29/202515.60 USD
9/26/202515.66 USD
9/25/202515.33 USD
9/24/202516.36 USD
9/23/202516.49 USD
9/22/202517.02 USD
9/19/202517.01 USD
9/18/202517.53 USD
9/17/202517.17 USD
9/16/202517.08 USD
9/15/202517.26 USD
9/12/202516.75 USD
9/11/202516.76 USD
9/10/202516.28 USD
9/9/202516.67 USD
9/8/202516.25 USD
9/5/202515.66 USD
9/4/202515.09 USD
9/3/202514.98 USD
9/2/202515.32 USD
8/29/202515.40 USD
8/28/202515.07 USD
8/27/202515.23 USD
8/26/202515.19 USD
8/25/202515.21 USD
8/22/202515.37 USD
8/21/202514.15 USD
8/20/202514.34 USD
8/19/202515.03 USD
8/18/202514.95 USD
8/15/202514.62 USD
8/14/202515.07 USD
8/13/202514.65 USD
8/12/202512.42 USD
8/11/202511.68 USD
8/8/202512.19 USD
8/7/202512.18 USD
8/6/202512.00 USD
8/5/202512.63 USD
8/4/202512.21 USD
8/1/202511.50 USD
7/31/202511.98 USD
7/30/202512.55 USD
7/29/202513.59 USD
7/28/202513.88 USD
7/25/202514.17 USD
7/24/202514.00 USD
Access this data via the Eulerpool API

Chemours Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
4.97 B USD
448.00 M USD
219.00 M USD
Jan 1, 2021
6.35 B USD
859.00 M USD
608.00 M USD
Jan 1, 2022
6.83 B USD
786.00 M USD
578.00 M USD
Jan 1, 2023
6.08 B USD
-110.00 M USD
-238.00 M USD
Jan 1, 2024
5.78 B USD
443.00 M USD
86.00 M USD
Jan 1, 2025
5.81 B USD
-5.00 M USD
-386.00 M USD
Jan 1, 2026 (e)
6.05 B USD
518.02 M USD
191.67 M USD
Jan 1, 2027 (e)
6.38 B USD
658.41 M USD
335.39 M USD

Chemours Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 24, 2026, 7:14 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201220132014201520162017201820192020202120222023202420252026e2027e
7.376.866.435.725.406.186.645.534.976.356.836.085.785.816.056.38
-7.61-6.87-6.23-11.12-5.5414.507.36-16.75-10.0827.697.66-11.02-4.870.454.105.56
31.9221.3421.1416.7020.5628.3729.6919.2421.4721.7723.6621.4919.9115.5315.5315.53
2.351.461.360.961.111.751.971.061.071.381.621.311.150.900.940.99
1.460.530.530.230.101.071.230.450.450.860.79-0.110.44-0.010.520.66
19.817.768.273.951.7817.3418.568.099.0213.5411.51-1.817.66-0.098.5710.31
1.060.420.40-0.090.010.751.00-0.050.220.610.58-0.240.09-0.390.190.34
-26.14-59.98-5.44-122.50-107.7810,557.1433.38-105.23-521.15177.63-4.93-141.18-136.13-548.84-149.4875.39
0.810.120.120.891.001.001.001.001.001.000.510.350.35
-85.19641.6712.36-49.00-31.37
150.55181.37181.37180.97186.04182.07167.87164.25164.76168.95150.05148.59149.83150.55150.55150.55
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Chemours generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Chemours retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Chemours's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Chemours has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Chemours's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Chemours stock margins

The Chemours margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Chemours. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Chemours.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
21.47 %
9.02 %
4.41 %
Jan 1, 2021
21.77 %
13.54 %
9.58 %
Jan 1, 2022
23.66 %
11.51 %
8.46 %
Jan 1, 2023
21.49 %
-1.81 %
-3.92 %
Jan 1, 2024
19.91 %
7.66 %
1.49 %
Jan 1, 2025
15.53 %
-0.09 %
-6.65 %
Jan 1, 2026 (e)
15.53 %
8.57 %
3.17 %
Jan 1, 2027 (e)
15.53 %
10.32 %
5.25 %

Chemours Stock Revenue, EBIT, Earnings per Share

The Chemours earnings per share therefore indicates how much revenue Chemours has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
30.16 USD
2.72 USD
1.33 USD
Jan 1, 2021
37.55 USD
5.08 USD
3.60 USD
Jan 1, 2022
45.53 USD
5.24 USD
3.85 USD
Jan 1, 2023
40.91 USD
-0.74 USD
-1.60 USD
Jan 1, 2024
38.59 USD
2.96 USD
0.57 USD
Jan 1, 2025
38.58 USD
-0.03 USD
-2.56 USD
Jan 1, 2026 (e)
40.24 USD
3.44 USD
1.28 USD
Jan 1, 2027 (e)
42.49 USD
4.37 USD
2.23 USD

Chemours business model & stock analysis

Chemours Co is a US-based chemical company that emerged from the DuPont Performance Chemicals division in 2015. With its headquarters in Wilmington, Delaware, the company employs over 7,000 employees worldwide and has an annual revenue of approximately $6 billion. The company's history dates back to 1802 when Eleuthère Irénée DuPont de Nemours established a powder mill in Wilmington. Over time, DuPont specialized in the production of chemicals for various applications including textiles, electronics, construction, transportation, and food. In 2015, the DuPont Performance Chemicals division was spun off as an independent company under the name Chemours Co. Chemours' business model is based on the development and production of chemicals for various applications including titanium dioxide pigments, fluoroproducts, Nafion membranes, Freon refrigerants, and optical materials. These products are utilized by various industries such as automotive, construction, chemicals, and electronics. The company is divided into three segments: Titanium Technologies, Fluor Technologies, and Chemical Solutions. Chemours' titanium dioxide pigments are produced in the Titanium Technologies segment and are a crucial component in paints, plastics, paper, and other materials. Fluor products, such as refrigerants and fluoropolymer coatings, are manufactured by the Fluor Technologies segment and find application in aerospace, automotive, and semiconductor production. The Chemical Solutions segment produces various chemicals for use in agriculture, oil and gas industry, fuel cell production, and other areas. One well-known product of Chemours is the refrigerant R-134a, marketed under the brand name Freon. This refrigerant was developed in the 1990s as a replacement for the ozone-depleting refrigerant R-12 (Freon 12) and is now widely used in vehicle air conditioning systems and other cooling systems. Another product of Chemours is Nafion membranes, used in fuel cells. These membranes enable the electrochemical reaction that converts hydrogen into electricity and water. Fuel cells are considered an environmentally-friendly energy source for vehicles and buildings. Chemours aims to produce chemicals that are safe, environmentally friendly, and sustainable. The company has developed its own sustainability strategy, which aims to reduce resource consumption, decrease dependence on non-renewable resources, and minimize environmental impact. Chemours has also implemented a comprehensive product safety and quality policy to ensure that all products meet the highest safety and quality standards. Overall, Chemours is a leading provider of chemicals used in a variety of industries. The company is committed to sustainability and product safety and is dedicated to continuously improving its processes and products.

Chemours Segments

Chemours Revenue by Segment (1/6)

  • 3 Years

  • 5 Years

  • Max

Titanium Dioxide
Fluorochemicals
Fluoropolymers
Opteon Refrigerants
Advanced Materials
Performance Solutions
Freon Refrigerants
Foam, Propellants, and Other
Mining Solutions
Sulfur
Minerals And Other
Performance Chemicals and Intermediates
Details
Date
Titanium Dioxide and Other Minerals
Titanium Dioxide
Fluorochemicals
Fluoropolymers and advanced materials
Fluoropolymers
Refrigerants
Opteon Refrigerants
Advanced Materials
Performance Solutions
Freon Refrigerants
Foam, Propellants, and Other
Mining Solutions
Sulfur
Minerals And Other
Performance Chemicals and Intermediates
Royalty Income
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
2.36 B USD
1.09 B USD
0.00 USD
1.17 B USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
262.00 M USD
127.00 M USD
0.00 USD
383.00 M USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
2.33 B USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
1.26 B USD
753.00 M USD
510.00 M USD
428.00 M USD
374.00 M USD
0.00 USD
0.00 USD
98.00 M USD
50.00 M USD
0.00 USD

Chemours Revenue by Segment (2/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Titanium dioxide and other minerals
Fluorochemicals
Fluoropolymers
Performance chemicals and intermediates
Mining Solutions
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Chemours Revenue by Segment (3/6)

  • 3 Years

  • 5 Years

  • Max

Titanium dioxide
Fluorochemicals
Fluoropolymers
Performance chemicals and intermediates
Mining Solutions
Details
Date
Titanium dioxide
Fluorochemicals
Fluoropolymers
Performance chemicals and intermediates
Mining Solutions
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2017
2.96 B USD
1.38 B USD
1.28 B USD
306.00 M USD
261.00 M USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Chemours Revenue by Segment (4/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Titanium Technologies
Fluoroproducts
Chemical Solutions
Other Operating Segment
Details
Date
Titanium Technologies
Fluoroproducts
Chemical Solutions
Other Operating Segment
Jan 1, 2015
2.39 B USD
2.23 B USD
1.10 B USD
0.00 USD
Jan 1, 2016
0.00 USD
2.26 B USD
0.00 USD
0.00 USD
Jan 1, 2017
2.96 B USD
0.00 USD
571.00 M USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
50.00 M USD

Chemours Revenue by Segment (5/6)

  • Max

Titanium technologies
Thermal and specialized solutions
Advanced performance materials
Details
Date
Titanium technologies
Thermal and specialized solutions
Advanced performance materials
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
2.43 B USD
2.07 B USD
1.26 B USD

Chemours Revenue by Segment (6/6)

  • Max

All segments
Other Non-Reportable Segment
Details
Date
All segments
Other Non-Reportable Segment
Jan 1, 2015
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
Jan 1, 2025
5.76 B USD
50.00 M USD

Chemours Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

North America
Europe, the Middle East, and Africa
Asia Pacific
EMEA
Latin America
Canada
Details
Date
North America
Europe, the Middle East, and Africa
Asia Pacific
EMEA
Latin America
Canada
Jan 1, 2015
2.57 B USD
0.00 USD
1.39 B USD
977.00 M USD
777.00 M USD
140.00 M USD
Jan 1, 2018
2.38 B USD
1.69 B USD
1.72 B USD
0.00 USD
855.00 M USD
0.00 USD
Jan 1, 2019
2.14 B USD
1.16 B USD
1.54 B USD
0.00 USD
676.00 M USD
0.00 USD
Jan 1, 2020
1.91 B USD
1.09 B USD
1.38 B USD
0.00 USD
585.00 M USD
0.00 USD
Jan 1, 2021
2.32 B USD
1.41 B USD
1.83 B USD
0.00 USD
789.00 M USD
0.00 USD
Jan 1, 2022
2.95 B USD
1.31 B USD
1.79 B USD
0.00 USD
745.00 M USD
0.00 USD
Jan 1, 2025
2.65 B USD
0.00 USD
1.24 B USD
1.16 B USD
748.00 M USD
0.00 USD

Chemours Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Chemours historical P/E ratio, EBIT multiple, and P/S ratio

Chemours annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Chemours shares outstanding

The number of shares of Chemours was 150.55 M in 2025. This indicates how many shares Chemours is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
164.76 M Stocks
Jan 1, 2021
168.95 M Stocks
Jan 1, 2022
150.05 M Stocks
Jan 1, 2023
148.59 M Stocks
Jan 1, 2024
149.83 M Stocks
Jan 1, 2025
150.55 M Stocks
Jan 1, 2026 (e)
150.55 M Stocks
Jan 1, 2027 (e)
150.55 M Stocks

Chemours Dividend History

12 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.09USDYTD
Feb 27, 20260.09USD 0.0%1/1
20250.51USD 48.7%
Feb 28, 20250.25USD 0.0%1/4
May 16, 20250.09USD 65.0%2/4
Aug 15, 20250.09USD 0.0%3/4
Nov 14, 20250.09USD 0.0%4/4
20241.00USD 0.0%
20231.00USD 0.0%
20221.00USD 0.0%
20211.00USD 0.0%
20201.00USD 0.0%
20191.00USD 19.0%
20180.84USD 600.0%
20170.12USD 0.0%

Chemours dividend history and estimates

In 2025, Chemours paid a dividend amounting to 0.51 USD. Dividend means that Chemours distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2020
1.00 USD
0.00 USD
Jan 1, 2021
1.00 USD
0.00 USD
Jan 1, 2022
1.00 USD
0.00 USD
Jan 1, 2023
1.00 USD
0.00 USD
Jan 1, 2024
1.00 USD
0.00 USD
Jan 1, 2025
0.51 USD
0.00 USD
Jan 1, 2026 (e)
0.09 USD
0.26 USD
Jan 1, 2027 (e)
0.00 USD
0.35 USD

Chemours dividend payout ratio

In 2025, Chemours had a payout ratio of -19.99%. The payout ratio indicates the percentage of the company's profits that Chemours distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
75.23 %
Jan 1, 2021
27.79 %
Jan 1, 2022
25.96 %
Jan 1, 2023
-62.43 %
Jan 1, 2024
174.22 %
Jan 1, 2025
-19.99 %
Jan 1, 2026 (e)
27.43 %
Jan 1, 2027 (e)
15.68 %

Current Chemours forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
20.00 %
Buy66.67 % (12)
Hold27.78 % (5)
Sell5.56 % (1)
12M Price Target
18.36
Last Price
17.47
Currency
USD
12M Return Potential
5.09 %
LTM Return
0 %

Chemours Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/3/20260.43USD1.70 BUSD2026 Q2
7/23/20260.43USD1.70 BUSD2026 Q2
5/5/2026-0.05USD1.43 BUSD2026 Q1
5/4/2026-0.05USD1.43 BUSD2026 Q1
2/19/20260.07USD1.37 BUSD2025 Q4
2/5/20260.07USD1.37 BUSD2025 Q4
4/25/20240.89USD1.62 BUSD2024 Q1
2/7/20240.23USD1.35 BUSD2023 Q4
7/26/20231.34USD1.67 BUSD2023 Q2
5/1/20230.73USD1.47 BUSD2023 Q1

EESG©

Eulerpool ESG Scorecard© for the Chemours stock

80/100
64
Environment
82
Social
93
Governance
E

Environment

20
Scope 1 - Direct Emissions3,392,000
Scope 2 - Indirect emissions from purchased energy1,059,000
Scope 3 - Indirect emissions within the value chain137,600,000
Total CO₂ emissions4,451,000
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees24
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees79
White Management Share81
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Chemours shareholder structure

% Name
15.87975%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
11.90546%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
4.08573%
State Street Investment Management (US)
State Street Investment Management (US)
2.99946%
Columbia Threadneedle Investments (US)
Columbia Threadneedle Investments (US)
2.42700%
Cooper Creek Partners Management LLC
Cooper Creek Partners Management LLC
2.40979%
JP Morgan Asset Management
JP Morgan Asset Management
...

Chemours Executives and Management Board

DD

Ms. Denise Dignam

(59)

President, Chief Executive Officer, Director · since 2021

Compensation5.89 M USD
KW

Ms. Kristine Wellman

(55)

Senior Vice President, General Counsel, Corporate Secretary

Compensation1.82 M USD
JM

Mr. Joseph Martinko

(57)

President - Thermal and Specialized Solutions

Compensation1.43 M USD
GC

Mr. Gerardo Calderon

(49)

President - Advanced Performance Materials

Compensation1.37 M USD
SH

Mr. Shane Hostetter

(43)

Chief Financial Officer

Compensation1.05 M USD

Frequently asked questions about Chemours

The business model of Chemours Co is centered around the production and sale of performance chemicals. Chemours specializes in areas such as titanium technologies, fluoroproducts, and chemical solutions. With a strong focus on innovation and sustainability, the company strives to provide solutions that fulfill market needs while minimizing environmental impact. Chemours leverages its expertise to develop and supply high-quality products across various industries, including automotive, electronics, and construction. By continually refining its products and processes, Chemours aims to create value for its customers and shareholders, maintaining a robust presence in the global chemical industry.

All fundamentals and in-depth analysis of Chemours

Our stock analysis for Chemours stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chemours. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.